XPO XPO notches 134 percent Q4 2025 EPS beat even as shares dip slightly in todays trading ARTV Artiva Bio drops 867 after Q4 2025 EPS posts narrow miss versus analyst estimates NTRB Nutriband posts far narrower Q1 2026 loss than analyst projections shares edge higher on positive investor sentiment